TB Management in Children
| Name | HAMURWA HC IV |
|---|
| Activity Title | TB Management in Children |
|---|
| Details | Consider TB in children with persistent cough, weight loss, fever, lymphadenopathy, or exposure history.
Use TST or IGRA for infection screening.
Chest X-ray helps identify pulmonary involvement.
Microbiological confirmation (gastric aspirates, induced sputum) is often challenging but essential; NAATs like GeneXpert are valuable.
2. Treatment:
First-line anti-TB drugs: Isoniazid, Rifampicin, Ethambutol, Pyrazinamide.
Standard duration: 6 months for pulmonary TB; longer for extrapulmonary or CNS TB.
Use child-friendly formulations.
Monitor for drug toxicity, especially hepatotoxicity.
3. Latent TB Infection (LTBI):
Indicated for close contacts, HIV-infected children.
Treatment: Isoniazid for 6-9 months, or shorter regimens like rifampicin for 4 months.
4. Special considerations:
Manage co-infections like HIV.
Watch for drug resistance; MDR-TB requires second-line drugs.
Support nutritional and psychosocial needs.
5. Prevention:
BCG vaccination at birth.
Contact tracing and prophylactic therapy for exposed children.
6. Follow-up:
Regular clinical assessments to monitor response and side effects.
Ensure adherence and completion of therapy
|
|---|
| Competence | General Medicine |
|---|
| Start Date | 02-10-2025 |
|---|
| End Date | 02-10-2025 |
|---|
| Event Time | 09:15 PM |
|---|
| Location | HAMURWA HC IV |
|---|
| Cost (UGX) | 0 |
|---|
| CPD Points | 2 |
|---|